IP-001

IP-001 · Immunophotonics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for IP-001, covering 2025-01-08 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases [Phase 2, Phase 3]

See pricing